Neuroblastoma Origin and Therapeutic Targets for Immunotherapy

por Kholodenko, Irina V., Kalinovsky, Daniel V., Doronin, Igor I., Deyev, Sergey M., Kholodenko, Roman V.
Publicado 2018

The Novel Peptide Chm-273s Has Therapeutic Potential for Metabolic Disorders: Evidence from In Vitro Studies and High-Sucrose Diet and High-Fat Diet Rodent Models

por Mitkin, Nikita A., Pavshintcev, Vsevolod V., Sukhanova, Iuliia A., Doronin, Igor I., Babkin, Gennady A., Sadagurski, Marianna, Malyshev, Anton V.
Publicado 2022

Ganglioside GD2 in reception and transduction of cell death signal in tumor cells

por Doronin, Igor I, Vishnyakova, Polina A, Kholodenko, Irina V, Ponomarev, Eugene D, Ryazantsev, Dmitry Y, Molotkovskaya, Irina M, Kholodenko, Roman V
Publicado 2014

RNA Sequencing-Based Identification of Ganglioside GD2-Positive Cancer Phenotype

por Sorokin, Maxim, Kholodenko, Irina, Kalinovsky, Daniel, Shamanskaya, Tatyana, Doronin, Igor, Konovalov, Dmitry, Mironov, Aleksei, Kuzmin, Denis, Nikitin, Daniil, Deyev, Sergey, Buzdin, Anton, Kholodenko, Roman
Publicado 2020

PeptoGrid—Rescoring Function for AutoDock Vina to Identify New Bioactive Molecules from Short Peptide Libraries

por Zalevsky, Arthur O., Zlobin, Alexander S., Gedzun, Vasilina R., Reshetnikov, Roman V., Lovat, Maxim L., Malyshev, Anton V., Doronin, Igor I., Babkin, Gennady A., Golovin, Andrey V.
Publicado 2019

Multimerization through Pegylation Improves Pharmacokinetic Properties of scFv Fragments of GD2-Specific Antibodies

por V. Kholodenko, Irina, V. Kalinovsky, Daniel, V. Svirshchevskaya, Elena, I. Doronin, Igor, V. Konovalova, Maria, V. Kibardin, Alexey, V. Shamanskaya, Tatyana, S. Larin, Sergey, M. Deyev, Sergey, V. Kholodenko, Roman
Publicado 2019

Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors

por Kalinovsky, Daniel V, Kibardin, Alexey V, Kholodenko, Irina V, Svirshchevskaya, Elena V, Doronin, Igor I, Konovalova, Mariya V, Grechikhina, Maria V, Rozov, Fedor N, Larin, Sergey S, Deyev, Sergey M, Kholodenko, Roman V
Publicado 2022

Minibody-Based and scFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells

por Kalinovsky, Daniel V., Kholodenko, Irina V., Kibardin, Alexey V., Doronin, Igor I., Svirshchevskaya, Elena V., Ryazantsev, Dmitriy Y., Konovalova, Maria V., Rozov, Fedor N., Larin, Sergey S., Deyev, Sergey M., Kholodenko, Roman V.
Publicado 2023

Peptide LCGA-17 Attenuates Behavioral and Neurochemical Deficits in Rodent Models of PTSD and Depression

por Malyshev, Anton V., Sukhanova, Iuliia A., Ushakova, Valeria M., Zorkina, Yana A., Abramova, Olga V., Morozova, Anna Y., Zubkov, Eugene A., Mitkin, Nikita A., Pavshintsev, Vsevolod V., Doronin, Igor I., Gedzun, Vasilina R., Babkin, Gennady A., Sanchez, Sergio A., Baker, Miah D., Haile, Colin N.
Publicado 2022

In silico Screening and Behavioral Validation of a Novel Peptide, LCGA-17, With Anxiolytic-Like Properties

por Malyshev, Anton V., Sukhanova, Iuliia A., Zlobin, Alexander S., Gedzun, Vasilina R., Pavshintsev, Vsevolod V., Vasileva, Ekaterina V., Zalevsky, Arthur O., Doronin, Igor I., Mitkin, Nikita A., Golovin, Andrey V., Lovat, Maxim L., Kovalev, Georgy I., Zolotarev, Yurii A., Kuchumov, Askar R., Babkin, Gennady A., Luscher, Bernhard
Publicado 2021